Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
Establishment Labs received FDA approval for 28 additional sizes of Motiva SmoothSilk Round and Ergonomix breast implants, including sizes as small as 105 cc. The expanded portfolio spans Mini, Demi and Full profiles and will be commercially available in the U.S. before the end of the year. Management expects the broader size range to accelerate U.S.
Key figures
- Drug Name
- Motiva SmoothSilk Round and Motiva SmoothSilk Ergonomix breast implants
- New sizes added
- 28
- Smallest size cc
- 105
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.